Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Knightscope
Sponsored
content by Knightscope
MA
MarketJar
Community Contributor
The Next Phase of Defense AI: A Robotic Response to America’s Security Gaps
Autonomous systems are no longer just a futuristic vision — they’re fast becoming an essential layer of national security. As AI reshapes everything from finance to warfare, physical security remains one of the most under-addressed frontiers.
View narrative
US$12.00
FV
51.2% undervalued
intrinsic discount
22.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
35
users have followed this narrative
7 days ago
author updated this narrative
Figma
TI
TickerTickle
Community Contributor
Figma (FIG): The S&P 500’s Design Standard Turning Into an All-in-One Platform
Watching Figma Grow Up I’ve been using Figma almost every single day for the past five years. As a product designer, it’s been my main tool for designing interfaces, testing and prototyping ideas, and also for working together with teams in different countries and time zones.
View narrative
US$65.70
FV
6.7% overvalued
intrinsic discount
30.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
Updated
narrative
Sleep Cycle
MA
Mandelman
Community Contributor
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.
View narrative
SEK 38.04
FV
19.4% undervalued
intrinsic discount
3.15%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
2
users have commented on this narrative
34
users have followed this narrative
Updated
narrative
JB Hi-Fi
RO
Robbo
Community Contributor
Has JB Hi-Fi Lost Its Point of Difference?
I may be showing my age here, but I feel that a decade or so ago, shopping at JB Hi-Fi was a different experience. There seemed to be a deliberate policy of employing sales staff from alternative subcultures, which gave the stores a unique, edgy vibe.
View narrative
AU$76.00
FV
53.6% overvalued
intrinsic discount
-0.45%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
1
users have commented on this narrative
6
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
VNET
VNET Group
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Chinese Data Center Buildout Will Suffer Under Mounting Pressures
Key Takeaways Overexpansion risks underused assets and squeezed margins amid maturing digital demand, increasing competition, and regulatory pressures in China's data center market. High debt levels and heavy capital needs heighten refinancing and dilution risks, while tightening tech and compliance restrictions threaten innovation and long-term profitability.
View narrative
US$5.71
FV
36.7% overvalued
intrinsic discount
14.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Capita
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Outsourcing Decline Will Pressure Margins Though Digital Efforts Boost Outlook
Key Takeaways Accelerating digital transformation and AI adoption generate strong growth opportunities, but automation threatens traditional outsourcing revenue and margins. Heavy investment in technology and restructuring provides efficiency gains, yet operational complexity, public sector reliance, and talent constraints limit scalability and margin expansion.
View narrative
UK£3.21
FV
26.6% undervalued
intrinsic discount
0.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Akebia Therapeutics
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Growing CKD Prevalence Will Fuel Global Oral Therapy Adoption
Key Takeaways Rapid adoption of Vafseo and streamlined regulatory strategy could significantly expand market reach and drive superior revenue growth domestically and internationally. Strong product performance, cost control, and resilience in legacy products support ongoing R&D investment and improved financial stability.
View narrative
US$10.00
FV
69.1% undervalued
intrinsic discount
22.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
SPG
SP Group
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Completion Of Atlanta Factory Will Expand Presence In North American Healthcare Market
Key Takeaways Strong growth in proprietary products and a new factory in Atlanta suggest potential for increased revenue and improved margins. Commitment to sustainability and a share buyback program may boost eco-conscious customer appeal and shareholder value.
View narrative
DKK 370.00
FV
27.3% undervalued
intrinsic discount
4.37%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
Updated
narrative
Hain Celestial Group
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Alison Lewis Will Improve Operational Efficiency And Secure Cost Savings
Key Takeaways Leadership changes and strategic review aim to boost operational efficiency, shareholder value, and financial health. Focus on cost savings, digital enhancement, and e-commerce drives revenue growth and better net margins.
View narrative
US$2.87
FV
38.6% undervalued
intrinsic discount
-1.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
BRC
AN
AnalystHighTarget
Consensus Narrative from 3 Analysts
Premium Coffee And DTC E-commerce Will Boost Expansion
Key Takeaways Rapid expansion in shelf presence, product variety, and energy drink market entry could drive outsized revenue growth and margin improvement, surpassing analyst expectations. Strong brand loyalty, premiumization trends, and operational efficiency initiatives position BRC to outpace legacy competitors and achieve sustained, higher-quality earnings.
View narrative
US$2.50
FV
37.6% undervalued
intrinsic discount
14.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
AVITA Medical
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
High Valuation Will Constrain Recovery Amid Regulatory And Cost Pressures
Key Takeaways Growing reimbursement challenges and payer pressure threaten revenue growth as sustaining premium pricing becomes increasingly difficult. Heavy reliance on RECELL and regulatory setbacks increase risk, while profitability and successful geographic expansion remain uncertain.
View narrative
US$3.00
FV
52.0% overvalued
intrinsic discount
20.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Nano-X Imaging
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Global Aging And Digitalization Will Accelerate Imaging Adoption
Key Takeaways Rapid digital ecosystem growth, early-career engagement, and mobile imaging offerings set the stage for widespread adoption and entrenched positioning in both mature and emerging healthcare markets. Accelerating AI partnerships, B2B2C models, and demand for preventative care drive operating leverage, recurring revenue streams, and a structurally more profitable business model.
View narrative
US$10.00
FV
60.3% undervalued
intrinsic discount
79.15%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Q-linea
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Overvaluation Will Persist As Italy And US Markets Evolve
Key Takeaways Growth and profitability assumptions rely on optimistic adoption rates and premium pricing, both threatened by slow expansions, budget constraints, and rising competition. High R&D costs, cash burn, and buyer bargaining power risk limiting future margin expansion, increasing dilution, and depressing earnings expectations.
View narrative
SEK 80.00
FV
37.0% undervalued
intrinsic discount
229.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies